A 3D-Printed System Allows Genes Responsible for Cranial Malformations to be “Silenced”

What if cranial malformations could be treated without surgery, directly at their genetic source? An Italian research team has developed a promising therapeutic strategy to address craniosynostosis, a condition characterized by premature fusion of the skull sutures in infants. The key lies in a “gene silencer” administered via nanoparticles and integrated into a 3D-printed hydrogel that acts locally and is minimally invasive.

In many cases, the most severe forms of craniosynostosis are caused by mutations in the FGFR2 gene, which is responsible for regulating bone growth. When this gene fails, the cranial sutures ossify too early, preventing normal brain development and causing severe deformities of the skull and face, as well as respiratory, auditory, and visual impairments. Currently, these conditions, such as Crouzon syndrome, can only be treated through invasive surgery performed within a few months of life and repeated throughout childhood. The new approach, still in the preclinical phase, aims for something different: correcting the problem at its molecular origin, without major surgical procedures.

Graphic summary of the 3D system for treating cranial malformations (image credits: Lattanzi et al., 2025).

The team coordinated by Professor Wanda Lattanzi, from the Università Cattolica del Sacro Cuore and the Policlinico Gemelli campus in Rome, has been working for years to understand these cellular mechanisms. The most recent result is the development of small interfering molecules, called siRNA, capable of exclusively “silencing” the mutated version of the FGFR2 gene.